Additional file 6: Table S4. of Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD

Andre Mattman (4855486); Don Sin (128552); Fernando Leitao Filho (4855489); Fernando Martinez (16458); Gerard Criner (2993709); Janice Leung (3586403); John Connett (4055053); Meilan Han (4055050); Prescott Woodruff (4055044); Richard Albert (4055059); Robert Reed (4055047); Robert Schellenberg (429772); S. Paul Man (4855483); Seung Ra (4055062); Shawn Aaron (390256); Stephen Lazarus (4055056)

Additional file 6: Table S4. of Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD

Authors: Andre Mattman (4855486)
Don Sin (128552)
Fernando Leitao Filho (4855489)
Fernando Martinez (16458)
Gerard Criner (2993709)
Janice Leung (3586403)
John Connett (4055053)
Meilan Han (4055050)
Prescott Woodruff (4055044)
Richard Albert (4055059)
Robert Reed (4055047)
Robert Schellenberg (429772)
S. Paul Man (4855483)
Seung Ra (4055062)
Shawn Aaron (390256)
Stephen Lazarus (4055056)
Publication date
Publisher
Doi

Abstract

Interactions between IgG subclass levels and inhaled steroid use at enrollment and use of systemic steroids in previous 12Â months for both outcomes of interest (time to first exacerbation and time to first hospitalization). (DOCX 15 kb

Similar works

Full text

Available Versions

FigShare

oai:figshare.com:article/58912...

Last time updated on 14/03/2018